Profiel
Donald S.
Brooks served as an Independent Director at CASI Pharmaceuticals, Inc. from 2011 to 2012.
He also held positions as an Independent Non-Executive Director at BioDiem Ltd., Director at Xenon Pharmaceuticals, Inc., and Senior Counsel-Licensing at Merck & Co., Inc. Brooks is a graduate of Columbia Law School.
Eerdere bekende functies van Donald S. Brooks
| Bedrijven | Functie | Einde |
|---|---|---|
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Directeur/Bestuurslid | 27-01-2012 |
| MERCK & CO., INC. | Algemeen Adviseur | 01-01-1993 |
BioDiem Ltd.
 BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia. | Directeur/Bestuurslid | - |
| XENON PHARMACEUTICALS INC. | Directeur/Bestuurslid | - |
Opleiding van Donald S. Brooks
| Columbia Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| XENON PHARMACEUTICALS INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
BioDiem Ltd.
BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia. | Health Technology |
